Search | IOVS | ARVO Journals

Showing 1 – 20 of 393

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

A Multimodal Implementation of RETFound Using Optic Nerve Head Fundus Photographs and OCT Imaging for Glaucoma Detection

Benton Gabriel Chuter; Vedant Joshi; Shahin Hallaj; Evan Walker; Jeffrey M Liebmann; Massimo Antonio Fazio; Christopher A Girkin; Robert Weinreb; Mark Christopher; Linda M Zangwill

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):386.

ARVO Annual Meeting Abstract June 2025

Remodeling of the Laminar Cribrosa Over Time Predicts Functional Loss in Primary Open Angle Glaucoma Patients.

Christopher A Girkin; Evan Walker; Karla Murillo; Anuwat Jiravarnsirikul; Linda M Zangwill; Robert Weinreb; Jeffrey M Liebmann; Massimo Antonio Fazio

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1160.

ARVO Annual Meeting Abstract June 2025

Using Major Vessel Position Measurements to Reduce OCT RNFL False Positives

Ari Leshno; Camila S Zangalli; Emmanouil (Manos) Tsamis; Donald C Hood; Charu Vyas; Vital Paulino Costa; Gustavo De Moraes; Aakriti Garg Shukla; George A Cioffi; Jeffrey M Liebmann; Noga Harizman

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2761.

ARVO Annual Meeting Abstract June 2025

Short term test-retest variability of OCT and visual field summary metrics

Yujia Wang; Iván Marin-Franch; Gustavo De Moraes; Ari Leshno; Aakriti Garg Shukla; Jeffrey M Liebmann; George A. Cioffi; Donald C Hood; Emmanouil Tsamis

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):6201.

ARVO Annual Meeting Abstract June 2025

Advancements in Glaucoma Detection through Fine-Tuning of Vision Language Models

Mark Christopher; JALIL JALILI; Justin Huynh; Evan Walker; Benton Gabriel Chuter; Christopher Bowd; Anna Heinke; Akram Belghith; Michael Henry Goldbaum; Massimo Antonio Fazio; Christopher A Girkin; C. Gustavo De Moraes; Jeffrey M Liebmann; Sally Liu Baxter; Robert Weinreb; Linda M Zangwill

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):407.

ARVO Annual Meeting Abstract June 2025

Visual Function Prediction Using Fine-Tuned Vision Language Models

Justin Huynh; JALIL JALILI; Evan Walker; Benton Gabriel Chuter; Christopher Bowd; Anna Heinke; Akram Belghith; Michael Henry Goldbaum; Massimo Antonio Fazio; Christopher A. Girkin; Gustavo De Moraes; Jeffrey M Liebmann; Sally Liu Baxter; Robert Weinreb; Linda M Zangwill; Mark Christopher

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):414.

ARVO Annual Meeting Abstract June 2025

Generating Clinical Descriptions from OCT in Glaucoma by Fine-Tuning a Multi-Modal Large Language Model

JALIL JALILI; Yashraj Gavhane; Evan Walker; Anna Heinke; Justin Huynh; Benton Gabriel Chuter; Christopher Bowd; Akram Belghith; Michael Henry Goldbaum; Massimo Antonio Fazio; Christopher A Girkin; Gustavo De Moraes; Jeffrey M Liebmann; Sally Baxter; Robert Weinreb; Linda M Zangwill; Mark Christopher

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):411.

ARVO Annual Meeting Abstract June 2025

Anatomically-Informed Cross Attention Network for Glaucoma Detection in OCT Volumes

Roshan Kenia; Anfei Li; Jedrzej Golebka; Angela McCarthy; Ives A Valenzuela; Aakriti Shukla; Jeffrey M Liebmann; George A Cioffi; Kaveri Thakoor

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):429.

Artificial Intelligence October 2024

Automated Identification of Clinically Relevant Regions in Glaucoma OCT Reports Using Expert Eye Tracking Data and Deep Learning

PDF

Ye Tian; Anurag Sharma; Shubh Mehta; Shubham Kaushal; Jeffrey M. Liebmann; George A. Cioffi; Kaveri A. Thakoor
TAGS: eye-tracking, glaucoma, deep learning, training
Trans. Vis. Sci. Tech.. 2024; 13(10):24. https://doi.org/10.1167/tvst.13.10.24

ARVO Annual Meeting Abstract June 2024

A Deep Learning Approach Accurately Estimates RNFL Thickness in OCT Scans Where Instrument-Native Segmentation Fails

Benton Gabriel Chuter; Justin Huynh; Mark Christopher; Ruben Cesar Gonzalez; Evan Walker; Sally Liu Baxter; Akram Belghith; Christopher Bowd; Michael Henry Goldbaum; Jeffrey M Liebmann; Massimo Antonio Fazio; Christopher A Girkin; Robert Weinreb; Linda M Zangwill

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2385.

ARVO Annual Meeting Abstract June 2024

OCT metrics for the macular region are more sensitive for detecting glaucomatous progression than OCT circumpapillary metrics

Iván Marin-Franch; Yujia Wang; Gustavo De Moraes; Ari Leshno; Aakriti Garg Shukla; Jeffrey M Liebmann; George A Cioffi; Donald C Hood; Emmanouil (Manos) Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1451.

ARVO Annual Meeting Abstract June 2024

Perimetric testing patterns focusing on the central visual field region can be more sensitive to glaucomatous progression than more peripheral patterns

Yujia Wang; Iván Marin-Franch; Carlos Gustavo De Moraes; Ari Leshno; Aakriti Garg Shukla; Jeffrey M Liebmann; George A. Cioffi; Donald Hood; Emmanouil Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4800.

ARVO Annual Meeting Abstract June 2024

Use of Topographical Structure–Function Agreement For Glaucoma Screening

Ari Leshno; Donald C Hood; Jeffrey M Liebmann; George A. Cioffi; Aakriti Garg Shukla; Yonatan Shalamaev; Raam Hasharoni; Zvia Burgansky-Eliash; Alon Skaat; Emmanouil (Manos) Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2518.

ARVO Annual Meeting Abstract June 2024

Eyes with particular patterns of retinal ganglion cell damage at baseline are more likely to show glaucomatous progression

Grace Mao; Yujia Wang; Elizabeth Ahn; Ari Leshno; Gustavo De Moraes; Aakriti Garg Shukla; George A Cioffi; Jeffrey M Liebmann; Donald C Hood; Emmanouil Tsamis

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2517.

ARVO Annual Meeting Abstract June 2024

Impact of Physical Activity Levels on Visual Field Progression in Individuals with Glaucoma

Je Hyun Seo; Takashi Nishida; Sasan Moghimi; Massimo Antonio Fazio; Christopher A Girkin; Jeffrey M Liebmann; Linda M Zangwill; Robert Weinreb

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4046.

ARVO Annual Meeting Abstract June 2024

Impact of Initial Rates of Retinal Nerve Fiber Layer Thinning on Glaucoma Progression

Vincent Pham; Takashi Nishida; Sasan Moghimi; Natchada Tansuebchueasai; Naimul Alam; Christopher A Girkin; Massimo Antonio Fazio; Jeffrey M Liebmann; Linda M Zangwill; Robert Weinreb

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2542.

ARVO Annual Meeting Abstract June 2024

A Randomized, Sham Controlled, Masked Phase II Study for Safety of Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for the Treatment of Glaucoma: Adverse Events and Structural Outcomes

Alexandria Dominguez; Gala Beykin; Mariana Nunez; Zac Wennberg Smith; George A. Cioffi; Jeffrey M Liebmann; Marzhan Atakulova; Davinder S. Grover; Jennifer Rinn; Alexus Schley; Jeffrey Louis Goldberg

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):942.

ARVO Annual Meeting Abstract June 2024

Racial and ethnic differences in baseline glaucoma disease severity

Sophie Gu; Ari Leshno; Aakriti Garg Shukla; George A Cioffi; Jeffrey M Liebmann

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2510.

ARVO Annual Meeting Abstract June 2024

Time to glaucoma progression detection by retinal nerve fiber layer thickness and visual field in individuals of African descent

Jo-Hsuan Wu; Sasan Moghimi; Evan Walker; Takashi Nishida; Gopikasree Gunasegaran; Natchada Tansuebchueasai; Jeffrey M Liebmann; Massimo Antonio Fazio; Christopher A Girkin; Linda M Zangwill; Robert Weinreb

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2509.

ARVO Annual Meeting Abstract June 2024

Estimation of 10-2 Visual Field Maps Based on 24-2 Visual Field Measurements in Glaucoma

Michael Saheb Kashaf; Golnoush Mahmoudinezhad; Sasan Moghimi; Jiacheng Cheng; Yu Xiang; Liyang Ru; Siavash Beheshtaein; Evan Walker; Mohsen Adelpour; Mark Christopher; Jeffrey M Liebmann; Christopher A Girkin; Massimo A. Fazio; Linda M Zangwill; Nuno Vasconcelos; Robert Weinreb

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2365.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A Multimodal Implementation of RETFound Using Optic Nerve Head Fundus Photographs and OCT Imaging for Glaucoma Detection

Remodeling of the Laminar Cribrosa Over Time Predicts Functional Loss in Primary Open Angle Glaucoma Patients.

Using Major Vessel Position Measurements to Reduce OCT RNFL False Positives

Short term test-retest variability of OCT and visual field summary metrics

Advancements in Glaucoma Detection through Fine-Tuning of Vision Language Models

Visual Function Prediction Using Fine-Tuned Vision Language Models

Generating Clinical Descriptions from OCT in Glaucoma by Fine-Tuning a Multi-Modal Large Language Model

Anatomically-Informed Cross Attention Network for Glaucoma Detection in OCT Volumes

Automated Identification of Clinically Relevant Regions in Glaucoma OCT Reports Using Expert Eye Tracking Data and Deep Learning

A Deep Learning Approach Accurately Estimates RNFL Thickness in OCT Scans Where Instrument-Native Segmentation Fails

OCT metrics for the macular region are more sensitive for detecting glaucomatous progression than OCT circumpapillary metrics

Perimetric testing patterns focusing on the central visual field region can be more sensitive to glaucomatous progression than more peripheral patterns

Use of Topographical Structure–Function Agreement For Glaucoma Screening

Eyes with particular patterns of retinal ganglion cell damage at baseline are more likely to show glaucomatous progression

Impact of Physical Activity Levels on Visual Field Progression in Individuals with Glaucoma

Impact of Initial Rates of Retinal Nerve Fiber Layer Thinning on Glaucoma Progression

A Randomized, Sham Controlled, Masked Phase II Study for Safety of Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for the Treatment of Glaucoma: Adverse Events and Structural Outcomes

Racial and ethnic differences in baseline glaucoma disease severity

Time to glaucoma progression detection by retinal nerve fiber layer thickness and visual field in individuals of African descent

Estimation of 10-2 Visual Field Maps Based on 24-2 Visual Field Measurements in Glaucoma

To View More...

You must be signed into an individual account to use this feature.